Myopia Profile

Science articles.

Learn about the latest scientific research and evidence-based innovations that are guiding decision-making for myopia management in clinical practice.

Our compendium of science reviews and summaries cover key papers, new developments and future possibilities in myopia, with a focus on clinical applications. Browse the latest articles or refine to your interest using the search box. Filter by topic, choose topic combinations, and apply the additional filter to limit your search to article types.

Myopia Control ProductsSee compendium
Article Type
Conference lecture summary Key paper Research paper Research paper abstract
Close Topic
Adult myopia Atropine Axial length Binocular vision Causes of myopia Combination treatment High myopia Light therapies Mechanisms Myopia control efficacy Ortho-k Pathology and eye health Pre-myopia Soft contact lenses Spectacles Treatment safety Untreated myopia progression Visual environment Visual performance
Close Myopia Progression After Ceasing MiSight 1 Day Treatment – 7-year study results Eye growth and myopia progression return to age-expected levels after stopping MiSight 1-day lenses, with no loss of prior treatment gains.Read Full Article Reviewing the evidence for vitamin D in myopia controlCan vitamin D help delay childhood myopia? This review examines the environmental, genetic, and biological research behind the association.Read Full Article New evidence for the influence of sleep on myopiaShort and long sleep duration were linked to myopia, but genetic analysis showed sleep traits may not independently influence myopia risk.Read Full Article Estimating axial length using refraction and keratometryThis study introduces a method to estimate axial length from standard optometric data, with 95% limits of agreement of ±0.73 mm.Read Full Article Additive effect of MiSight and 0.05% atropine in childrenAdding MiSight to 0.05% atropine reduced myopia progression by an additional 0.38 D and axial elongation by 0.19 mm over 1 year in children with rapid progression.Read Full Article Tighter regulation of RLRL devices for myopia in ChinaChina reclassifies RLRL devices as high-risk, suspending their use pending stricter safety and efficacy data.Read Full Article CARE myopia control spectacle lenses: one year data Two designs of CARE lenses reduced myopia progression by just under 50% after one year, with only around 15% progressing more than 0.75D.Read Full Article What Do Different Age Groups Really Know About Myopia?Age-specific insights into myopia knowledge, behaviours, and strategies for targeted eye care advice.Read Full Article Myopia linked to lower AMD and DR risk, higher glaucoma riskMyopia is linked to reduced risk of AMD and diabetic retinopathy, but a higher risk of open-angle glaucoma, especially in high myopia.Read Full Article Essilor Stellest lenses: 5-year results5-year follow-up results of spectacle lenses with highly aspherical lenslets for myopia control provide further long-term efficacy data.Read Full Article OK Lenses show superior myopia control for higher myopiaOrthokeratology outperformed DIMS lenses in slowing myopia progression, especially for moderate to high myopia, over a one-year period.Read Full Article Digital screen time and myopia: how much is too much?A dose-response meta-analysis suggests keeping screen time under 1 hour daily may help reduce myopia risk in children.Read Full Article

Enormous thanks to our visionary sponsors

Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.